Mirodenafil dihydrochloride (Aribio)
米罗那非二盐酸盐 (Aribio)
Report date: 2024/05/15 14:19:12
Base Information
Drug NameMirodenafil dihydrochloride (Aribio)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[13]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAribio Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdPanacro (Hefei) Pharmaceutical Technology Co LtdNeuCo United Co Ltd +[7]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A